Catalyst
Slingshot members are tracking this event:
Fibrocell Reports Phase II azficel-T Trial for Treatment of Vocal Cord Scarring Did Not Meet Primary Endpoints
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| FCSC |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 08, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Azficel-t, Fcx-007, Dystrophic Epidermolysis Bullosa, Grade, Roughness, Breathiness, Asthenia
